The Annals Evolution of Clinical Pharmacy | Now Available
home help contact us subscription past issues search current issue
QUICK SEARCH:   [advanced]


     


Published Online, 3 June 2004, www.theannals.com, DOI 10.1345/aph.1D269.
 The Annals of Pharmacotherapy: Vol. 38, No. 7, pp. 1252-1257. DOI 10.1345/aph.1D269
© 2004 Harvey Whitney Books Company.
This Article
Right arrow Résumé Freely available
Right arrow Extracto Freely available
Right arrow Full Text
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Taylor, J. R
Right arrow Articles by Lopez, L. M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Taylor, J. R
Right arrow Articles by Lopez, L. M

AMBULATORY CARE

Cholesterol: Point-of-Care Testing

James R Taylor, PharmD CDE

Clinical Assistant Professor, Department of Pharmacy Practice, College of Pharmacy, University of Florida, Gainesville, FL

Larry M Lopez, PharmD FCCP

Professor and Associate Chairman, Department of Pharmacy Practice, College of Pharmacy, University of Florida

Reprints: James R Taylor PharmD CDE, Department of Pharmacy Practice, College of Pharmacy, University of Florida, PO Box 100486, Gainesville, FL 32610-0486, fax 352/273-6242, jtaylor{at}cop.ufl.edu

OBJECTIVE: To review the literature regarding point-of-care (POC) cholesterol monitors and describe their role in pharmacy practice.

DATA SOURCES: Primary articles were identified by a MEDLINE search (1966–May 2003); references cited in these articles provided additional resources.

STUDY SELECTION AND DATA EXTRACTION: All of the articles identified from this search were reviewed, and all information deemed relevant was included.

DATA SYNTHESIS: Hyperlipidemia is a well-established risk factor for coronary artery disease, which is the leading cause of death in the US. The use of POC cholesterol monitors may help to improve the identification and management of this disease. Pharmacists may use many of these devices in their practice and are also in an ideal position to provide patient education on selection and use of these monitors and interpretation of the results.

CONCLUSIONS: The availability of POC cholesterol monitors has increased in recent years. Based on currently available data, these monitors are best suited for screening purposes and to assist in the management of hyperlipidemia. There is not enough evidence to support the notion that POC cholesterol monitors can replace laboratory or office monitoring. Their application in the diagnosis of hyperlipidemia is also currently limited.

Key Words: hyperlipidemia, point-of-care tests

Published Online, June 3, 2004. www.theannals.com, DOI 10.1345/aph.1D269


This article has been cited by other articles:


Home page
 The Annals of PharmacotherapyHome page
R. A Dale, L. H Jensen, and M. J Krantz
Comparison of Two Point-of-Care Lipid Analyzers for Use in Global Cardiovascular Risk Assessments
Ann. Pharmacother., May 1, 2008; 42(5): 633 - 639.
[Abstract] [Full Text] [PDF]


homecopy help contact us subscription past issues search current issue
Copyright © 2004 by Harvey Whitney Books Company.